HANSOH PHARMAC. HD-00001 (3KY) — Cash Flow Quality Index
HANSOH PHARMAC. HD-00001 (3KY) has a Cash Flow Quality Index of 1.21x as of December 2025. Operating cash flow of €6.74 Billion exceeds net income of €5.56 Billion, indicating high earnings quality where cash backs reported profits. Explore HANSOH PHARMAC. HD-00001 (3KY) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HANSOH PHARMAC. HD-00001 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for HANSOH PHARMAC. HD-00001 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See HANSOH PHARMAC. HD-00001 balance sheet independence to measure how much of total assets are equity-financed.
Annual Cash Flow Quality Index for HANSOH PHARMAC. HD-00001 (2021–2025)
Year-by-year earnings quality comparison for HANSOH PHARMAC. HD-00001. For the full cash flow conversion analysis, see 3KY cash flow metrics.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | €6.74 Billion | €5.56 Billion | ▲ +37.3% |
| 2024 | 0.88x | €3.86 Billion | €4.37 Billion | ▼ -7.1% |
| 2023 | 0.95x | €3.12 Billion | €3.28 Billion | ▼ -10.4% |
| 2022 | 1.06x | €2.74 Billion | €2.58 Billion | ▲ +11.7% |
| 2021 | 0.95x | €2.58 Billion | €2.71 Billion | — |